N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane
C25H33F2N7O — CID 159863838
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane
N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane (PubChem CID 159863838) has the molecular formula C25H33F2N7O and a molecular weight of 485.58 g/mol. Its IUPAC name is N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane.
Molecular Properties
| Compound Name | N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane |
|---|---|
| PubChem CID | 159863838 |
| Molecular Formula | C25H33F2N7O |
| Molecular Weight | 485.58 g/mol |
| Exact Mass | 485.27 |
| IUPAC Name | N-cyclopropyl-4-[8-(2,6-difluoroanilino)-2-(propan-2-ylamino)purin-9-yl]cyclohexane-1-carboxamide;methane |
| SMILES | C.CC(C)Nc1ncc2nc(Nc3c(F)cccc3F)n(C3CCC(C(=O)NC4CC4)CC3)c2n1 |
| InChI | InChI=1S/C24H29F2N7O.CH4/c1-13(2)28-23-27-12-19-21(32-23)33(24(30-19)31-20-17(25)4-3-5-18(20)26)16-10-6-14(7-11-16)22(34)29-15-8-9-15;/h3-5,12-16H,6-11H2,1-2H3,(H,29,34)(H,30,31)(H,27,28,32);1H4 |
| InChIKey | NRMGQKANFOOYBF-UHFFFAOYSA-N |
| XLogP | 5.31 |
| TPSA | 96.76 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.58 |
| LogP ≤ 5 | 5.31 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159863838 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.